| Name |
|---|
SSSCA1 GeneSjogren syndrome/scleroderma autoantigen 1 This antigen is recognized by a subset of anti-centromere antibodies from patients with scleroderma and/or Sjogren's syndrome. Subcellular localization has not yet been established. [provided by RefSeq, Jul 2008] |
SNORC Genesecondary ossification center associated regulator of chondrocyte maturation Predicted to be involved in cartilage development. Predicted to be located in several cellular components, including collagen-containing extracellular matrix; cytoplasm; and extracellular region. Predicted to be active in cell periphery. [provided by Alliance of Genome Resources, Mar 2025] |
CMM Genecutaneous malignant melanoma/dysplastic nevus Malignant melanoma is a malignant neoplasm of melanocytes, arising de novo or from a pre-existing benign nevus, which occurs most often in the skin but also may involve other sites.[supplied by OMIM, Jul 2002] |
CTAGE1 Genecutaneous T-cell lymphoma-associated antigen 1 Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport; protein secretion; and vesicle cargo loading. Predicted to be located in membrane. Predicted to be active in endoplasmic reticulum exit site and endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Mar 2025] |
CMM4 GeneMelanoma, cutaneous malignant, 4 |
CMM7 GeneMelanoma, cutaneous malignant, susceptibility to, 7 |
LOC100421663 Genecutaneous T-cell lymphoma-associated antigen 1 pseudogene |
LOC100421630 Genecutaneous T-cell lymphoma-associated antigen 1 pseudogene |
LOC100288590 Genecutaneous T-cell lymphoma-associated antigen 1 pseudogene |
PICSAR GeneP38 inhibited cutaneous squamous cell carcinoma associated lincRNA |